Currault Douglas N. II 4
4 · FREEPORT-MCMORAN INC · Filed May 1, 2024
Insider Transaction Report
Form 4
Currault Douglas N. II
EVP & General Counsel
Transactions
- Sale
Common Stock
2024-04-29$51.99/sh−55,000$2,859,368→ 164,067 total - Exercise/Conversion
Options (Right to Buy)
2024-04-29−25,000→ 25,000 totalExercise: $11.87From: 2020-02-05Exp: 2029-02-05→ Common Stock (25,000 underlying) - Exercise/Conversion
Common Stock
2024-04-29$18.74/sh+30,000$562,200→ 194,067 total - Exercise/Conversion
Options (Right to Buy)
2024-04-29−30,000→ 0 totalExercise: $18.74From: 2019-02-06Exp: 2028-02-06→ Common Stock (30,000 underlying) - Exercise/Conversion
Common Stock
2024-04-29$11.87/sh+25,000$296,750→ 219,067 total
Footnotes (3)
- [F1]The price reported represents the weighted average price of the shares sold. Shares were sold at varying prices in the range of $51.9400 - $52.0250. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F2]Amount beneficially owned includes 38,000 Restricted Stock Units.
- [F3]33% exercisable on the date indicated and 33% exercisable on each of the next two anniversaries thereof.